GlassScriptPhysician profile
Syed A Raza
NPI 1740252139
$1,215.68
in general payments reported to CMS, 2019-2025
15 companies · $281 in 2025
The $281 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.42 · 2020: $20.23 · 2021: $182 · 2022: $196 · 2023: $122 · 2024: $373 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $397.31 | 2021-2025 | Venaseal, Ellipsys Vascular Access System |
| Endologix LLC | $158.83 | 2022 | |
| Terumo Medical Corporation | $136.52 | 2025 | Azur Cx Detachable |
| Penumbra, INC. | $124.88 | 2021 | |
| Irhythm Technologies, INC. | $109.29 | 2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals LP | $71.18 | 2025 | Lynparza |
| Abbott Laboratories | $40.42 | 2019 | |
| Abiomed | $38.66 | 2025 | |
| Becton, Dickinson and Company | $36.41 | 2024 | Venclose Maven Catheter |
| Philips North America LLC | $25.64 | 2023 | |
| Smith+Nephew, INC. | $22.61 | 2024 | Collagenase Santyl |
| Angiodynamics, INC. | $20.23 | 2020 | |
| Bard Peripheral Vascular, INC. | $20.17 | 2022 | |
| Cook Medical LLC | $13.53 | 2023 | Tornado |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Raza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.